Literature DB >> 16427502

Laser-mediated photodynamic therapy.

Macrene Alexiades-Armenakas1.   

Abstract

Photodynamic therapy (PDT) has evolved since its inception at the beginning of the 20th century, when it was defined as an oxygen-dependent reaction between a photosensitizing dye and light. Photosensitizers and light sources have since been continually optimized for distinct applications and tissues. Systemic porphyrins, such as hematoporphyrin, were the first photosensitizers to be used, mostly to treat tumors. The first light sources used were broad-band, noncoherent lights, such as quartz, xenon, tungsten, or halogen lamps. The wavelengths of light chosen were based upon the absorption spectrum of porphyrins: blue because the largest peak is at 400 nm (the Soret band) and red because of its greater penetration depth but lesser absorption at 650 nm (a Q band). Systemic photosensitizers caused prolonged photosensitivity, and broad-band light sources had limitations and side effects. The development of topical photosensitizers, such as 5-aminolevulinic acid, and the advent of lasers in recent years have advanced PDT for cutaneous use. In the 1990s, red lasers were applied to PDT because of their increased skin penetration despite lesser absorption by porphyrins. Broad-band blue light and red light have been studied extensively, the former achieving Food and Drug Administration approval in combination with topical aminolevulinic acid for the treatment of actinic keratosis in 1997. These lasers and light sources caused significant side effects, such as discomfort, erythema, crusting, blistering, and dyspigmentation. The recent application of the long-pulsed pulsed dye laser (595 nm) after topical aminolevulinic acid greatly minimized side effects without compromising efficacy. Long-pulsed pulsed dye laser-mediated PDT has since been shown to be effective in treatment of actinic keratosis, actinic cheilitis, sebaceous hyperplasia, lichen sclerosus, and, most recently, acne vulgaris. Finally, intense pulsed light sources have been introduced to PDT for the treatment of photodamage and acne, offering advantages of versatility in wavelengths and applications.

Entities:  

Mesh:

Year:  2006        PMID: 16427502     DOI: 10.1016/j.clindermatol.2005.10.027

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  19 in total

1.  Effect of a newly synthesized Zn sulfophthalocyanine derivative on cell morphology, viability, proliferation, and cytotoxicity in a human lung cancer cell line (A549).

Authors:  Sello Lebohang Manoto; Heidi Abrahamse
Journal:  Lasers Med Sci       Date:  2011-01-29       Impact factor: 3.161

2.  Toxicity of photodynamic therapy with LED associated to Photogem®: an in vivo study.

Authors:  Flávia Zardo Trindade; Ana Cláudia Pavarina; Ana Paula Dias Ribeiro; Vanderlei Salvador Bagnato; Carlos Eduardo Vergani; Carlos Alberto de Souza Costa
Journal:  Lasers Med Sci       Date:  2011-04-06       Impact factor: 3.161

3.  Comparison of a new nanoform of the photosensitizer chlorin e6, based on plant phospholipids, with its free form.

Authors:  Lyubov V Kostryukova; Vladimir N Prozorovskiy; Natalya V Medvedeva; Olga M Ipatova
Journal:  FEBS Open Bio       Date:  2018-01-02       Impact factor: 2.693

4.  Characterization of the role of the photosensitizer, deuteporfin, in the detection of lymphatic metastases in a pancreatic cancer xenograft model.

Authors:  Xinzhe Yu; Hengchao Li; Deliang Fu; Chen Jin; J I Li
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

5.  Time course of apoptosis induced by photodynamic therapy with PsD007 in LT12 acute myeloid leukemia cells.

Authors:  Huijuan Yin; Xuying Ye; Qing Niu; Chao Wang; Yingxin Li
Journal:  Lasers Med Sci       Date:  2016-02-09       Impact factor: 3.161

6.  Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.

Authors:  Sanjay Anand; Golara Honari; Tayyaba Hasan; Paul Elson; Edward V Maytin
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

Review 7.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

Review 8.  Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Authors:  Christine B Warren; Laszlo J Karai; Allison Vidimos; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2009-12       Impact factor: 11.527

Review 9.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.

Authors:  Petras Juzenas; Wei Chen; Ya-Ping Sun; Manuel Alvaro Neto Coelho; Roman Generalov; Natalia Generalova; Ingeborg Lie Christensen
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

10.  A study of actinic cheilitis treatment by two low-morbidity CO2 laser vaporization one-pass protocols.

Authors:  Flávio Francisco de Godoy Peres; Adriana Aigotti Haberbeck Brandão; Yasmin Rodarte Carvalho; Ulysses Dória Filho; Hélio Plapler
Journal:  Lasers Med Sci       Date:  2008-06-14       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.